Target intelligence / Profile preview

Tripartite motif containing 44 (TRIM44)

Target
TRIM44
Molecular classification
Other (TRIM family protein), Protein quality control regulator, Deubiquitinase, DNA damage response regulator
01

Overview

Tripartite motif containing 44 (TRIM44) is a member of the TRIM protein family, distinguished by its conserved domains including zinc finger, B-box, coiled-coil, and glutamate-rich regions[1][2]. Unlike canonical TRIM proteins, TRIM44 lacks a RING domain, separating it from classic E3 ligases; however, it functions as a deubiquitinase and protein quality control factor[2]. TRIM44 links the ubiquitin-proteasome system with autophagy by promoting SQSTM1/p62 oligomerization, supporting the removal of misfolded or aggregated proteins through targeting them for autophagic degradation[1]. It is upregulated in multiple myeloma and other aggregate-prone diseases, where it can promote cell survival and pathological changes such as bone destruction[1]. TRIM44 also plays a role in DNA damage response by interacting with PARP1 and the ATM/MRN complex, dictating cell sensitivity to PARP inhibitors and coordinating double-strand break repair[2]. Thus, TRIM44 is a multifunctional regulatory protein at the crossroads of proteostasis, autophagy, and DNA repair, making it a candidate therapeutic target in cancers and neurodegenerative diseases.

Other names
TRIM44Tripartite motif protein 44
02

Mechanism of action

Modulation of autophagy and proteasome pathway activity; Regulation of DNA damage response signaling via PARP1 and ATM/MRN complex; Promotion of SQSTM1/p62 oligomerization and aggregate clearance; Influencing cell sensitivity/resistance to proteasome and PARP inhibition.

03

Biological functions

Regulation of protein quality controlProtein aggregate clearanceAutophagy activationDNA damage response signalingProtein deubiquitinationCell survival under proteotoxic stress
04

Disease associations

CancerNeurodegenerative diseaseOther (generally involved in diseases tied to protein homeostasis dysregulation)
05

Safety considerations

Potential resistance to proteasome inhibitors in cancer therapyTherapeutic modulation may affect normal cell proteostasis and DNA repairPossible effects on bone homeostasis (in myeloma)
06

Interacting drugs

Bortezomib

1 more in the full profile.

07

Biomarkers

TRIM44 protein expression (upregulation in multiple myeloma and possibly other cancers)Co-expression with SQSTM1/p62 or NFE2L2/NRF2 (may indicate activation of autophagy/aggregate clearance pathways)Interaction with DNA damage markers (e.g., γH2AX)

Beyond the preview

Go deeper on Tripartite motif containing 44 (TRIM44).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tripartite motif containing 44 (TRIM44).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call